Global Herpes Simplex Keratitis Treatment Industry, as per the FMI study, eyes a 6.1% CAGR, aiming for a valuation of US$ 8,022.9 Million By 2033
The global herpes simplex keratitis treatment industry showcased resilience in 2023, hitting an estimated value